These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18317223)

  • 21. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Borderline ovarian tumors. Current data].
    Duvillard P
    Ann Pathol; 1996 Nov; 16(5):396-405. PubMed ID: 9004728
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant mixed müllerian tumor of the ovary: report of a case and review of the literature.
    Shy SW; Lee WH; Lee MS; Lee MC
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):468-73. PubMed ID: 8281496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.
    Bedaiwy MA; Hussein MR; Biscotti C; Falcone T
    Pathol Oncol Res; 2009 Mar; 15(1):81-8. PubMed ID: 18575828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas.
    Dubé V; Roy M; Plante M; Renaud MC; Têtu B
    Int J Gynecol Pathol; 2005 Apr; 24(2):138-46. PubMed ID: 15782070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis.
    Matsuzaki S; Darcha C
    Hum Reprod; 2012 Mar; 27(3):712-21. PubMed ID: 22215621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seromucinous Tumors of the Ovary. What's in a Name?
    Kurman RJ; Shih IeM
    Int J Gynecol Pathol; 2016 Jan; 35(1):78-81. PubMed ID: 26598986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium.
    Ong A; Maines-Bandiera SL; Roskelley CD; Auersperg N
    Int J Cancer; 2000 Feb; 85(3):430-7. PubMed ID: 10652437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor expression is a common feature of ovarian borderline tumors.
    Abu-Jawdeh GM; Jacobs TW; Niloff J; Cannistra SA
    Gynecol Oncol; 1996 Feb; 60(2):301-7. PubMed ID: 8631556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunohistochemical study on keratin expression of uterine reserve cells].
    Yuminamochi T; Ishii Y; Nakazawa K; Hosogaya S; Kume S; Suda K
    Rinsho Byori; 1994 Jan; 42(1):70-4. PubMed ID: 7509006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term.
    Turbiner J; Amin MB; Humphrey PA; Srigley JR; De Leval L; Radhakrishnan A; Oliva E
    Am J Surg Pathol; 2007 Apr; 31(4):489-500. PubMed ID: 17414095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative proteomics of ovarian epithelial tumors.
    An HJ; Kim DS; Park YK; Kim SK; Choi YP; Kang S; Ding B; Cho NH
    J Proteome Res; 2006 May; 5(5):1082-90. PubMed ID: 16674097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinico-pathological spectrum of primary ovarian malignant mixed mullerian tumors (OMMMT) from a tertiary cancer institute: A series of 27 cases.
    Menon S; Deodhar K; Rekhi B; Dhake R; Gupta S; Ghosh J; Maheshwari A; Mahantshetty U; Shrivastva S; Budukh A; Tongaonkar HB; Kerkar R
    Indian J Pathol Microbiol; 2013; 56(4):365-71. PubMed ID: 24441223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant mesodermal (Mullerian) mixed tumor of the ovary: histologic, immunohistochemical and cytologic study].
    Ermilova VD; Smirnov AV; Sokolova VK; Kovrigina AM; Nikokgosian SO
    Arkh Patol; 1998; 60(3):48-52. PubMed ID: 9702303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
    Kim DJ; Lee MH; Park TI; Bae HI
    J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotype of human ovarian malignancies (cystadenocarcinomata and mixed müllerian tumor) established in SCID mice.
    Schumacher U; Adam E; Dietl J; Horny HP
    Exp Mol Pathol; 1997 Apr; 64(2):103-13. PubMed ID: 9316588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature.
    Roma AA; Malpica A; Deavers MT
    Int J Gynecol Pathol; 2011 Mar; 30(2):158-62. PubMed ID: 21293284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary study of neuroendocrine differentiation and its mechanism in ovarian epithelial tumors].
    Jiang LY; Wang ZN; Luo X; Xu JP; Xie XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1081-3. PubMed ID: 17666356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms.
    Giordano G; Azzoni C; D'Adda T; Rocco A; Gnetti L; Froio E; Merisio C; Melpignano M
    Pathol Res Pract; 2008; 204(3):163-74. PubMed ID: 18180113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.